The page is the record's research on the issuer — no analyst, no rating, no view. # Rapport Therapeutics, Inc. (NASDAQ: RAPP) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Rapport Therapeutics, Inc., listed on NASDAQ under ticker RAPP, with ISIN US75383L1026. The LEI is not on the record, as there is no GLEIF record with the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 116 filings on 68 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 3 days. The latest filing is a results filing dated 2026-11-04, 4 days before the record date of 2026-11-08. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days, and a median latency of 5.0 days, across 4359 issuers. The sector median for 2834 Pharmaceutical Preparations is 63.0 filings, a median cadence gap of 6.0 days, and a median latency of 4.0 days, across 526 issuers. The issuer has 3 agm_egm, 5 corporate_news, 56 directors_dealings, 6 prospectus, 38 regulatory_filing and 8 results filings in the window. ## Auditor The auditor of record is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002012593.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/RAPP (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/RAPP (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/RAPP · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp